AFAP1L2
Actin filament-associated protein 1-like 2
Also known as: AF1L2_HUMAN, Em:AC005383.4, FLJ14564, KIAA1914, XB130
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q8N4X5
- Gene
- AFAP1L2
- Ensembl
- ENSG00000169129
- Chromosome
- 10
- Canonical length
- 818 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Plasma membrane,Cytosol
OverviewNCBI Gene
Enables SH2 domain binding activity; SH3 domain binding activity; and protein tyrosine kinase activator activity. Involved in several processes, including positive regulation of epidermal growth factor receptor signaling pathway; regulation of gene expression; and regulation of mitotic cell cycle. Located in cytosol and plasma membrane. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
818 residues, UniProt reviewed canonical sequence.
>Q8N4X5|AFAP1L2
1 MERYKALEQL LTELDDFLKI LDQENLSSTA LVKKSCLAEL LRLYTKSSSS DEEYIYMNKV
61 TINKQQNAES QGKAPEEQGL LPNGEPSQHS SAPQKSLPDL PPPKMIPERK QLAIPKTESP
121 EGYYEEAEPY DTSLNEDGEA VSSSYESYDE EDGSKGKSAP YQWPSPEAGI ELMRDARICA
181 FLWRKKWLGQ WAKQLCVIKD NRLLCYKSSK DHSPQLDVNL LGSSVIHKEK QVRKKEHKLK
241 ITPMNADVIV LGLQSKDQAE QWLRVIQEVS GLPSEGASEG NQYTPDAQRF NCQKPDIAEK
301 YLSASEYGSS VDGHPEVPET KDVKKKCSAG LKLSNLMNLG RKKSTSLEPV ERSLETSSYL
361 NVLVNSQWKS RWCSVRDNHL HFYQDRNRSK VAQQPLSLVG CEVVPDPSPD HLYSFRILHK
421 GEELAKLEAK SSEEMGHWLG LLLSESGSKT DPEEFTYDYV DADRVSCIVS AAKNSLLLMQ
481 RKFSEPNTYI DGLPSQDRQE ELYDDVDLSE LTAAVEPTEE ATPVADDPNE RESDRVYLDL
541 TPVKSFLHGP SSAQAQASSP TLSCLDNATE ALPADSGPGP TPDEPCIKCP ENLGEQQLES
601 LEPEDPSLRI TTVKIQTEQQ RISFPPSCPD AVVATPPGAS PPVKDRLRVT SAEIKLGKNR
661 TEAEVKRYTE EKERLEKKKE EIRGHLAQLR KEKRELKETL LKCTDKEVLA SLEQKLKEID
721 EECRGEESRR VDLELSIMEV KDNLKKAEAG PVTLGTTVDT THLENVSPRP KAVTPASAPD
781 CTPVNSATTL KNRPLSVVVT GKGTVLQKAK EWEKKGASLocalizationUniProt · AlphaFold · HPA
Whether an antibody against AFAP1L2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.53
- Highest tissue expression
- 77 nTPM
Expression across tissuesHPA
Tissue
- thyroid gland: 77 nTPM
- parathyroid gland: 65 nTPM
- spleen: 61 nTPM
- seminal vesicle: 23 nTPM
- endometrium: 22 nTPM
- fallopian tube: 22 nTPM
Single-cell type
- tuft cells: 265 nCPM
- oligodendrocyte progenitor cells: 214 nCPM
- renal collecting duct principal cells: 136 nCPM
- schwann cells: 131 nCPM
- podocytes: 127 nCPM
- renal connecting tubule cells: 113 nCPM
Immune cell
- T-reg: 1.8 nTPM
- memory B-cell: 1.6 nTPM
- naive B-cell: 1.6 nTPM
- memory CD8 T-cell: 1.2 nTPM
- MAIT T-cell: 1.1 nTPM
- memory CD4 T-cell: 1.1 nTPM
Brain region
- cerebellum: 33 nTPM
- amygdala: 25 nTPM
- spinal cord: 21 nTPM
- thalamus: 20 nTPM
- pons: 20 nTPM
- white matter: 20 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.49
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.65
- DepMap mean gene effect
- 0.08
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- inflammatory response
- positive regulation of DNA-templated transcription
- positive regulation of epidermal growth factor receptor signaling pathway
- positive regulation of interleukin-8 production
- regulation of interleukin-6 production
- regulation of mitotic cell cycle
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of AFAP1L2 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads AFAP1L2 as an antibody target. Whether an autoantibody or antibody against AFAP1L2 could matter depends on whether native AFAP1L2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
AFAP1L2 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label AFAP1L2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...